Wes Brazell

Wes Brazell

Chief Financial Officer

Wes Brazell is the Chief Financial Officer of Xequel Bio. He’s been with Xequel Bio since February 2022. Wes is responsible for the company’s financial functions, including accounting, analysis, audit, treasury, corporate finance and investor relations. He is also responsible for overseeing the company’s compliance function.

Wes was previously the Chief Financial Officer of Eyevance Pharmaceuticals and brings 30 years experience in life sciences, with varied experiences in financial management, business development, international operations, and corporate strategy.

His favorite thing about working for Xequel Bio is the energy and passion in bringing new technologies to patients, as well as the reward of seeing these technologies grow and flourish. Wes is a history buff who enjoys music and water sports in his spare time.